Online now!✨RESEARCH: Norheim et al perform a randomized controlled trial in COPD patients, testing whether boosting NAD levels reduces airway inflammation, and exploring the impact on aging processes @ScheibyeKnudsen@CPorsbjerg@RespBispebjerg https://t.co/EHbqW6HGIq
Proudly presenting our new song about #severeasthma patients being able to #breatheeasy
Cudos to maestro Kjell Haakonsson and his AI team at Suno👍
This will be the Asthma dance tune of Summer 24!🪅💃🏼🕺🏻
https://t.co/RjxG8bFbaU
#remission#breathe#newlife@RespBispebjerg
Inducible laryngeal obstruction and breathing pattern disorder are common causes of breathlessness. Multidisciplinary assessment can prevent unnecessary medication use, hospital admissions and facilitate effective management of these complex conditions. https://t.co/rAVkGqUndg
The Blue Journal thanks Emerging Investigator Christian U. Woehlk, M.D., Ph.D., for his contribution to the May 1 issue.
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study)
@Cwhlk
https://t.co/JzZACRu5Yv
Deligthed to see our paper out, demonstrating a universal role of mast cells in asthma - but with different localizations across asthma phenotypes. #asthma#phenotype#ahr. #mastcellsmatter https://t.co/sG1a4CcNyJ
Happy to see our research highlighted by the ERS!
A key takeaway for daily practice is the need for routine airway inflammometry - not only in specialized SA clinics - as eosinophilia otherwise is overlooked in a large proportion of patients @RespBispebjerg@PluZdk@CPorsbjerg
Extremely proud to share our first study coming out of the VITAL study: "Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma" https://t.co/JmK1hHnxWf #asthma#Immunology#Immunotherapy@RespBispebjerg
Excited to share our recent findings highlighting airway eosinophilia - and in particular eosinophil degranulation - as a key player in severe asthma patients with bronchiectasis.
https://t.co/8lJjZRfxL1
In this real life cohort of asthma patients we compare expression of biomarkers - including induced sputum - across asthma severity. https://t.co/ONrAlaeYWu
ERJOR: This prospective cohort study confirms that patients with dysfunctional breathing experience dyspnoea and an abnormal breathing pattern when faced with undertaking everyday exercise challenges, such as climbing stairs https://t.co/Z2s6MRLGt4
Price et al., Diagnosis and management of allergy and respiratory disorders in sport: An #EAACI task force position paper
Read more👉https://t.co/Ad58PD25DD
See more #EAACIPositionPapers published in #Allergy👉 https://t.co/vIIRBH1CEo
@OliverJPrice #Allergy_journal
📢Currently #3TR is conducting the ABC study under the leadership of 🇩🇰 Prof. @CPorsbjerg, 🇳🇱 Prof. @AnkeHilse & 🇪🇺 @EuroRespSoc to find new #immunological treatment approaches for 🫁 severe #asthma patients. See how it all started in February this year!👉 https://t.co/iHEbHmEeWK
Really happy to share our findings on the missingness of induced sputum, which we believe calls for changes in how paired sputum samples are analysed.
https://t.co/jI02EuMIpG
Delighted to announce the launch of EILO Practicum Foundation. Thu 30 Sep 2021 (virtual event) Tickets are limited so book early to avoid disappointment. All booking details & course content are available on the link below 👇🏻. https://t.co/OE1sOMW08t
Just out: in our new international multi-centre collaboration (n=1,007) patients with #EILO on average waited 2 years to diagnosis and 20% were mistreated for #asthma. Open Access, early view here: https://t.co/rRAsI4EVZi
@Breathe_to_win@LarsPedersenDK@theotherdodd@argetzin